Catalyst Wire Dossier Catalyst Wire Dossier

Fibringlue

· Anterogen Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fibringlue, covering 2025-09-29 to 2025-09-29. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula [Phase 3]

See pricing